Psoriasis is a common, chronic, and inflammatory skin disease with a high burden on
individuals, health systems, and society worldwide. With the immunological pathologies and …

Background Psoriasis and obesity are risk factors for psoriasis. Therefore, we conducted a
comprehensive review and meta-analysis to determine the prevalence of obesity in patients …

Background: Psoriasis is a chronic and immune-mediated inflammatory skin disease. Many
studies have shown that curcumin (CUR) has strong anti-inflammatory effects and can …

As our understanding of the pathogenesis of psoriasis has evolved over the past two
decades, so has the number of treatment options. The introduction of biologic agents …

Abstract Ligusticum chuanxiong Hort (Ligusticum; Apiaceae)(accepted name, Ligusticum
striatum DC, on “The Plant List” for the latest version) is a Chinese herbal medicine (CHM) …

The introduction of biologic agents for the treatment of psoriasis has revolutionized the
current treatment landscape, targeting cytokines in the interleukin (IL)-23/IL-17 pathway and …

Psoriasis is a long-lasting skin condition characterized by redness and thick silver scales on
the skin's surface. It involves various skin cells, including keratinocytes, dendritic cells, T …

Psoriasis is one kind of autoimmune skin disease without efficiency cure. Shikonin (SHK) is
a potential drug for psoriasis treatment. Recent study suggested that ferroptosis involved in …

Background: Psoriasis, a chronic autoimmune condition, imposes significant burdens on
patients' well-being. While corticosteroid medications are commonly used, their prolonged …

Psoriasis is a chronic inflammatory skin disease affecting 2–3% of the global population.
Traditional systemic treatments, such as methotrexate, cyclosporine, acitretin and fumaric …